Skip to main content

Series A Biotechnology Companies

Explore 768 biotechnology startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
768
Total Funding
$808.6M
Avg Funding
$32.3M
Cities
21

Export 768 Series A Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Pittsburgh, United States
$48.0M
raised

ai3Bio develops treatments to transform the lives of patients with cancer.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Tübingen, Germany
$13.7M
raised

ViferaXS is a clinical-stage biotechnology company developing peptide-based cancer immunotherapies.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$3.7M
raised

Apollon develops noninvasive continuous glucose monitoring systems.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Durham, United States
$25.0M
raised

Ramona develops high-throughput microscopy tools to unlock previously impossible experiments within the modern biology lab.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Paris, France
$34.4M
raised

Biolevate provides an AI platform for life sciences teams to manage regulated operations through evidence-driven, auditable workflows.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 768 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Mountain View, United States
$10.0M
raised

ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Robigo is a biomanufacturing company engineering microbes to create more sustainable crop protection solutions.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Geleen, The Netherlands
$16.0M
raised

Matisse Pharmaceuticals is a biopharmaceutical company developing therapies for sepsis and septic shock by targeting cytotoxic histones.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Hong Kong, Hong Kong
$5.0M
raised

Connexus Therapeutics is a private, venture-backed biotechnology startup.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Minneapolis, United States
$5.5M
raised

Evia Bio is a life sciences innovation company that develops non-DMSO cryopreservation solutions.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 768 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Emeryville, United States
$44.0M
raised

RegCell develops cell therapies designed to restore immune tolerance in autoimmune diseases.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Boston, United States
$225.0M
raised

Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Singapore, Singapore
$1.7M
raised

N&E Innovations is a med-tech company that develops antimicrobial products.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$62.5M
raised

TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

New York, United States
$55.0M
raised

Tectora Therapeutics is a biotechnology company developing oral medicines for immune-mediated diseases.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 768 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Seattle, United States
$116.0M
raised

BrainChild Bio develops chimeric antigen receptor T-cell therapies engineered to treat tumors of the central nervous system.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Sevilla, Spain
$12.8M
raised

Vaxdyn is a developer of multi-valent vaccines for preventing antibiotics-resistant infections.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

$7.9M
raised

SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth (xerostomia) and dry eye conditions.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$56.3M
raised

Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Liège, Belgium
$9.6M
raised

Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 768 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Beaverton, United States
$150K
raised

Trace Biosciences creates fluorescence imaging agents for real-time nerve visualization during surgery.

Jul 2026
Series A

Founder Contacts

41,000+ verified contacts

San Diego, United States
$3.3M
raised

Cooler Heads is a healthtech company that develops a portable scalp cooling system designed for chemotherapy patients.

Jul 2026
Series A

Founder Contacts

41,000+ verified contacts

San Mateo, United States
$21.0M
raised

Elio Labs develops an optical computing technology to improve sensing capabilities across diverse cellular environments.

Jul 2026
Series A

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$24.0M
raised

Transcripta Bio is a company that focuses on drug development at a size and pace never seen before, with a lower risk.

Jul 2026
Series A

Founder Contacts

41,000+ verified contacts

Singapore, Singapore
$8.0M
raised

Tikva Allocell is a biotechnology company that specializes in next-gen cell therapies.

Jul 2026
Series A

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 768 companies

Ready to Connect with Series A Biotechnology Startups?

Get verified founder emails, funding details, and company data for 768 series a biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked